The groundbreaking approach of the medication represents a major advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – providing enhanced https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment